Subcutaneous (SubQ) Glutathione Injections Format: Administered just under the skin using a fine needle Use Case: Ideal for lower doses, sustained release over time Duration: Typically administered daily or several times per week, depending on protocol Advantages: Injectable method for at-home use Less invasive than IV or IM formats Allows for consistent, low-dose delivery Considerations: Not suitable for high-dose protocols Slightly slower onset compared to IV or IM methods Who It's For: Individuals who prioritize convenience and prefer lower maintenance options
Reduced Gastrointestinal Side Effects: The gradual onset and sustained presence of the medication, facilitated by weekly dosing, can help the body adapt, potentially minimizing common gastrointestinal side effects such as nausea, vomiting, and bloating during dose escalation
Research into sublingual semaglutide is still ongoing, but initial studies have shown positive results
Clarke, S
Glutathione injections, like infusions, involve administering glutathione directly into the bloodstream
However, nausea is the most commonly reported adverse effect, with incidence varying by medication and dose: approximately 15-30% for most GLP-1 agonists and up to 30-44% at higher doses of semaglutide and tirzepatide according to FDA prescribing information